Kylie Harness
Psychiatric/Mental Health · Indianapolis, INNPI 1033893565
Payments from drug & device makers
Across 84 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$394
- Axsome Therapeutics, Inc.$287
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$184
- Otsuka America Pharmaceutical, Inc.$183
- Takeda Pharmaceuticals U.S.A., Inc.$137
- AbbVie$116
- plus $610 from 16 others
What the payments were for
- Food & beverage$1,910100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 15 | $394 |
| Axsome Therapeutics, Inc. | 9 | $287 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $184 |
| Otsuka America Pharmaceutical, Inc. | 9 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $137 |
| AbbVie | 7 | $116 |
| Neurocrine Biosciences, Inc. | 4 | $87 |
| Ironshore Pharmaceuticals Inc. | 4 | $77 |
| Theratechnologies Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $71 |
| Corium, LLC | 2 | $43 |
| Tris Pharma Inc | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Gilead | 1 | $31 |
| Seqirus USA Inc | 1 | $30 |
| Novo Nordisk | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Viiv Healthcare Company | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Medtronic | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$427
- Auvelity$122
- ARISTADA INITIO$107
How this compares
$1,910 in reported general payments places this provider in the 70th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clomipramine Hcl | 25 | $848 |
| Buspirone Hcl | 29 | $563 |
| Quetiapine Fumarate | 35 | $212 |
| Bupropion XlBupropion Hcl | 20 | $181 |
| Eszopiclone | 19 | $161 |
| Escitalopram Oxalate | 26 | $156 |
| Hydroxyzine Hcl | 14 | $132 |
| Clonazepam | 24 | $54 |
| Trazodone Hcl | 18 | $53 |
| Diazepam | 19 | $49 |
| Lorazepam | 11 | $46 |
| Sertraline Hcl | 21 | $29 |
| Alprazolam | 15 | $25 |
| Clonidine Hcl | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Indianapolis
- Sonya RuedlingerIndianapolis$134K
- Devan GravesIndianapolis$12K
- Clyde YanIndianapolis$9K
- Beth DelamboIndianapolis$7K
- Olga Marie JiodioIndianapolis$6K
- Lindsay RussellIndianapolis$5K
- Nina VoigtIndianapolis$5K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.